The surge in popularity of drugs like Ozempic, driven in part by its weight loss benefits, is contributing to a record-high ...

A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s ...

The U.S. Food and Drug Administration removed Eli Lilly's blockbuster weight-loss and diabetes drugs from its shortage list ...

It may be time to add Covid-19 infection to the list of possible risk factors for developing type 2 diabetes at a young age.

The FDA has removed two of Eli Lilly's in-demand weight-loss and diabetes drugs from its shortage list. Diabetes drug ...

Pharmacists can continue making compounded versions of generic tirzepatide, the active ingredient in popular medications ...

Eli Lilly has finally made enough supply of its popular medicine tirzepatide to meet soaring demand ... just months after the ...

Hoping your company will begin paying for anti-obesity medications like Wegovy? You may be in luck. A growing number of ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

Just like when you find a glitzy resort in your dream destination, your first question about weight loss drugs might be, how ...

Shares in Hims & Hers Health fell after the U.S. Food and Drug Administration said Eli Lilly's obesity and diabetes drugs are no longer in shortage. Shares were down 7% in premarket trading to $17.64.